Skip to main content

Advertisement

Log in

Naftopidil versus flopropione as medical expulsive therapy for distal ureteral stones: results of a randomized, multicenter, double-blind, controlled trial

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

A multicenter, double-blind, randomized, controlled trial was conducted to determine the efficacy of naftopidil as medical expulsive therapy (MET) for patients with distal ureteral stones.

Methods

Ninety-two patients presenting with a single distal ureteral stone ≤10 mm were randomly assigned to receive either naftopidil (75 mg of naftopidil once in the morning and placebo twice a day) or flopropione (80 mg three times a day). The primary end point was time to stone expulsion calculated by the Kaplan–Meier method. Secondary end points were the percentages of patients who required analgesics, hospital admission, and surgery, the number of working days lost to the disease, and treatment safety.

Results

Overall, three patients were excluded from the final analysis. No significant differences were noted in age, stone size, and stone side between the treatment arms. The median time to stone expulsion was 8 days [95 % confidence interval (CI), 3–16] for the naftopidil group, and this was significantly less than the 18 days (95 % CI, 11 to not reached) for the flopropione group (p = 0.03). On multivariate Cox regression analysis, the hazard of expulsion was 1.8-fold higher for the naftopidil group than for the flopropione group after adjustment for age, sex, stone side, and stone size. No significant differences were noted in the secondary end points.

Conclusions

The administration of naftopidil significantly improved time to stone expulsion in patients with distal ureteral stones ≤10 mm. We believe that this is the first multicenter, double-blind, randomized, controlled trial demonstrating the efficacy of naftopidil for MET.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Seitz C, Liatsikos E, Porpiglia F, Tiselius HG, Zwergel U (2009) Medical therapy to facilitate the passage of stones: What is the evidence? Eur Urol 56:455–471

    Article  PubMed  Google Scholar 

  2. Fan B, Yang D, Wang J, Che X, Li X, Wang L et al (2013) Can tamsulosin facilitate expulsion of ureteral stones? A meta-analysis of randomized controlled trials. Int J Urol 20:818–830

    Article  CAS  PubMed  Google Scholar 

  3. Hollingsworth JM, Rogers MA, Kaufman SR, Bradford TJ, Saint S, Wei JT et al (2006) Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 368:1171–1179

    Article  PubMed  Google Scholar 

  4. Lu Z, Dong Z, Ding H, Wang H, Ma B, Wang Z (2012) Tamsulosin for ureteral stones: a systematic review and meta-analysis of a randomized controlled trial. Urol Int 89:107–115

    Article  CAS  PubMed  Google Scholar 

  5. Parsons JK, Hergan LA, Sakamoto K, Lakin C (2007) Efficacy of alpha-blockers for the treatment of ureteral stones. J Urol 177:983–987

    Article  CAS  PubMed  Google Scholar 

  6. Malin JM Jr, Deane RF, Boyarsky S (1970) Characterisation of adrenergic receptors in human ureter. Br J Urol 42:171–174

    Article  PubMed  Google Scholar 

  7. Itoh Y, Kojima Y, Yasui T, Tozawa K, Sasaki S, Kohri K (2007) Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol 14:749–753

    Article  CAS  PubMed  Google Scholar 

  8. Takei R, Ikegaki I, Shibata K, Tsujimoto G, Asano T (1999) Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors. Jpn J Pharmacol 79:447–454

    Article  CAS  PubMed  Google Scholar 

  9. Kumar S, Kurdia KC, Ganesamoni R, Singh SK, Nanjappa B (2013) Randomized controlled trial to compare the safety and efficacy of naftopidil and tamsulosin as medical expulsive therapy in combination with prednisolone for distal ureteral stones. Korean J Urol 54:311–315

    Article  PubMed Central  PubMed  Google Scholar 

  10. Lu JL, Tang QL, De Liu F, Hui JH (2012) Naftopidil and tolterodine in the medical expulsive therapy for intramural ureteral stones: a prospective randomized study. Urol Res 40:757–762

    Article  CAS  PubMed  Google Scholar 

  11. Ohgaki K, Horiuchi K, Hikima N, Kondo Y (2010) Facilitation of expulsion of ureteral stones by addition of alpha1-blockers to conservative therapy. Scand J Urol Nephrol 44:420–424

    Article  CAS  PubMed  Google Scholar 

  12. Sun X, He L, Ge W, Lv J (2009) Efficacy of selective alpha1D-blocker naftopidil as medical expulsive therapy for distal ureteral stones. J Urol 181:1716–1720

    Article  CAS  PubMed  Google Scholar 

  13. Zhou SG, Lu JL, Hui JH (2011) Comparing efficacy of alpha1D-receptor antagonist naftopidil and alpha1A/D-receptor antagonist tamsulosin in management of distal ureteral stones. World J Urol 29:767–771

    Article  CAS  PubMed  Google Scholar 

  14. Ohkawa M, Miyazaki K, Kuroda K (1977) Effect of Cospanon for spontaneous passage of ureteral stone. Hinyokika Kiyo 23:403–407

    Google Scholar 

  15. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ et al (2010) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 340:c869

    Article  PubMed Central  PubMed  Google Scholar 

  16. Fernbach SK, Maizels M, Conway JJ (1993) Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology. Pediatr Radiol 23:478–480

    Article  CAS  PubMed  Google Scholar 

  17. Ferre RM, Wasielewski JN, Strout TD, Perron AD (2009) Tamsulosin for ureteral stones in the emergency department: a randomized, controlled trial. Ann Emerg Med 54:432–439 9 e1–e2

    Article  PubMed  Google Scholar 

  18. Hermanns T, Sauermann P, Rufibach K, Frauenfelder T, Sulser T, Strebel RT (2009) Is there a role for tamsulosin in the treatment of distal ureteral stones of 7 mm or less? Results of a randomised, double-blind, placebo-controlled trial. Eur Urol 56:407–412

    Article  PubMed  Google Scholar 

  19. Vincendeau S, Bellissant E, Houlgatte A, Dore B, Bruyere F, Renault A et al (2010) Tamsulosin hydrochloride vs placebo for management of distal ureteral stones: a multicentric, randomized, double-blind trial. Arch Intern Med 170:2021–2027

    Article  CAS  PubMed  Google Scholar 

  20. Abdel-Meguid TA, Tayib A, Al-Sayyad A (2010) Tamsulosin to treat uncomplicated distal ureteral calculi: a double blind randomized placebo-controlled trial. Can J Urol 17:5178–5183

    PubMed  Google Scholar 

  21. Al-Ansari A, Al-Naimi A, Alobaidy A, Assadiq K, Azmi MD, Shokeir AA (2010) Efficacy of tamsulosin in the management of lower ureteral stones: a randomized double-blind placebo-controlled study of 100 patients. Urology 75:4–7

    Article  PubMed  Google Scholar 

  22. Kaneko T, Matsushima H, Morimoto H, Tsuzaka Y, Homma Y (2010) Efficacy of low dose tamsulosin in medical expulsive therapy for ureteral stones in Japanese male patients: a randomized controlled study. Int J Urol 17:462–465

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standard

The study was approved by the Institutional Review Board of Wakayama Medical University (registration No. 385) and therefore was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasuo Kohjimoto.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kohjimoto, Y., Hagino, K., Ogawa, T. et al. Naftopidil versus flopropione as medical expulsive therapy for distal ureteral stones: results of a randomized, multicenter, double-blind, controlled trial. World J Urol 33, 2125–2129 (2015). https://doi.org/10.1007/s00345-015-1556-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-015-1556-x

Keywords

Navigation